There were 981 press releases posted in the last 24 hours and 190,064 in the last 365 days.

Companion Diagnostics Market Growth in the United States has Risen Dramatically - Industry Forecast, 2019-2026

Companion Diagnostic

Increase in demand for personalized medicine across the regions with increase in popularity of companion diagnostics major drive the market growth.

Rise in prominence of personalized medicine, surge in cases of adverse drug reactions, and advancements in technologies for diagnostic techniques drive the growth in the companion diagnostics market”
— Mangesh Panhale
PORTLAND, OR, UNITED STATES, October 14, 2020 /EINPresswire.com/ -- UPDATE AVAILABLE ON-DEMAND

The report on the global companion diagnostics market highlights that the market is expected to reach $1,678 million by 2018, from $6,452 million in 2026, growing at a CAGR of 18.3% from 2019 to 2026. The report offers the current market size and forecasts along with Porter’s Five Forces analysis to help market players, stakeholders, startups, and investors to determine the current scenario and take further steps for the future. Drivers and opportunities for highest revenue generating and fastest growing segments would help in tapping into specific segment to achieve growth. Moreover, regional analysis would assist in expansion strategies for the market players and startups.

Rise in prominence of personalized medicine, surge in cases of adverse drug reactions, and advancements in technologies for diagnostic techniques drive the growth in the market. However, unfavorable reimbursement policies in various countries hinder the market growth. On the other hand, surge in incidences of cancer across the globe and a significant rise in healthcare expenditure create new opportunities in the industry.

To Get the Sample Copy of Report Visit @ https://www.alliedmarketresearch.com/request-sample/3735

Polymerase chain reaction (PCR) segment to maintain its dominant position by 2026

Based on technique type, the polymerase chain reaction (PCR) segment contributed nearly half of the total market share in 2018 and is expected to maintain its dominant position during the forecast period. This is due to high sensitivity, cost-effectiveness, and specificity along with its usage for simple automated platforms. On the other hand, the next-generation sequencing (NGS) segment would register the fastest CAGR of 19.7% from 2019 to 2026, owing to fewer turnaround times and its role in revolutionizing fields such as personalized medicine, genetic diseases, and clinical diagnostics. The report also discusses immunohistochemistry, in situ hybridization, and others.

Oncology segment register the highest market share throughout the forecast period

Based on indication, the oncology segment held the major market share in 2018, accounting for more than 90% of the total market. This segment is also anticipated to register the highest market share throughout the forecast period. Moreover, it is expected to grow at the highest CAGR of 18.5% from 2019 to 2026. This is due to increase in incidence of breast cancer and growing R&D activities for targeted drugs. The research also analyzes neurology and other segments.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/3735

North America to continue its lead status by 2026

North America contributed the largest share in terms of revenue, accounting for more than two-fifths of the total share in 2018, and is estimated to continue its lead status by 2026. This is due to high demand for advanced diagnostic techniques, increase in availability of trained medical professionals, and surge in number of research activities for developing new therapeutics. Asia-Pacific is estimated to grow at the highest CAGR of 20.4% from 2019 to 2026, owing to its high population base, increase in incidence of cancer, surge in awareness about companion diagnostics, and rise in demand for advanced medical diagnostics systems.

The Major Key Players Are:

• Abbott Laboratories Molecular, Inc.
• Agilent (Dako Denmark A/S)
• ARUP Laboratories, Inc.
• BioMerieux SA
• Danaher Corporation (Leica Microsystems)
• Foundation Medicine, Inc.
• Myriad Genetics, Inc.
• Qiagen N.V.
• Roche (Ventana Medical Systems Inc.)
• Thermo Fisher Scientific (Life Technologies Corporation).

Access Full Report @ https://www.alliedmarketresearch.com/companion-diagnostic-market

Similar Reports:

Dental Diagnostic and Surgical Equipment Market Industry Forecast, 2027

Infectious Disease Diagnostic Market Analysis and Industry Forecast, 2027

Diagnostic Catheters Market Analysis and Industry Forecast, 2027

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn